This patent covers our drug-device combination through March 2043,” said Matt Pauls, J.D., M.B.A, Chair and Chief Executive Officer, Savara. “With 10 years of Orphan Drug regulatory exclusivity upon ...
Savara (SVRA) announced the European Patent Office has issued patent No. 4 496 611 titled, “Drug-Device Combination Comprising a Liquid Solution ...
Our vision is of a world where food systems ensure the long-term health and sustainability of people, the planet, and economies. FoodSystems 2030 is an Umbrella Multi-Donor Trust Fund that helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback